Richtlijn Galweg- en Galblaascarcinoom Versie - Oncoline

2269
2270
2271
2272
2273
2274
2275
2276
2277
2278
2279
2280
2281
2282
2283
2284
2285
2286
2287
2288
2289
2290
2291
2292
2293
2294
2295
2296
2297
2298
2299
2300
2301
2302
2303
2304
2305
2306
2307
2308
2309
2310
2311
2312
2313
2314
2315
2316
2317
Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ, et al . Gallbladder cancer: differences
in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am
Coll Surg. 2011 Jan;212(1):50-61. Epub 2010 Nov 12. PubMed PMID: 21075015.
Chijiiwa K, Nakano K, Ueda J et. Surgical treatment of patients with T2 gallbladder carcinomainvading
the subserosal layer. J Am Coll Surg. 2001;192:600-7.
Chijiiwa K, Yamaguchi K, Tanaka M. Clinicopathologic differences between long-term and short-term
postoperative survivors with advanced gallbladder carcinoma. World J Surg. 1997 Jan;21(1):98-102.
PubMed PMID: 8943185.
Choi JY, Kim MJ, Lee JM, Kim KW, Lee JY, Han JK, Choi BI. Hilar Cholangiocarcinoma: Role of
preoperative Imaging with Sonography, MDCT, MRI, and Direct Cholangiography. AJR Am J Roentgenol.
2008 Nov;191(5):1448-57. Review.
Chung YE, Kim MJ, Park YN, Lee YH, Choi JY. Staging of extrahepatic cholangiocarcinoma. Eur Radiol.
2008 Oct;18(10):2182-95. Epub 2008 May 6. Review.
Connor S, Barron E, Redhead DN, Ireland H, et al. Palliation for suspected unresectable hilar
cholangiocarcinoma. EJSO;2007;33:341-345
Chryssou E, Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinoma: MR correlation with surgical
and histological findings. Clin Radiol. 2010 Oct;65(10):781-8. Epub 2010 Jul 31.
Cubertafond P, Gainant A, Ccchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results
of the French Surgical Association Survey. Ann Surg. 1994;219:275-80.
D’Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of
resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16:806-16.
De Bellis M, Sherman S, Fogel EL et al. Tissue sampling at ERCP in suspected malignant biliary
strictures (part 1). Gastrointest. Endosc 2002; 56:552–6.
DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD et al.
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;
245(5):755-62.
Downing SR, Cadogan KA, Ortega G, et al. Early-stage gallbladder cancer in the surveillance,
epidemiology, and the end results database. Arch Surg. 2011;146:734-8.
Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorail
Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485-9.
Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T. Nimura Y. Hepatectomy with portal vein resection
for hilar cholangiocarcinoma. Ann Surg 2003; 238: 720-27
Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M. Portal Vein Embolization before
Extended Hepatectomy for Biliary Cancer: Current Technique and Review of 494 Consecutive
Embolizations. Dig Surg. 2012;29(1): 23-9.
Concept Richtlijn galweg- en galblaascarcinoom vs accoord werkgroep Pagina 66 van 75
11 juli 2012